Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China
BackgroundThe National Drug Price Negotiation (NDPN) policy is a key institutional reform in China that reshaped drug market access rules. While its effects on drug prices and accessibility are well documented, evidence on firm-level innovation performance remains limited. This study evaluates the i...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-11-01
|
| シリーズ: | Frontiers in Public Health |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1705030/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|